QQQ0.49%

Trending

PLTR5.17%

Info

home SymbolBAX

Exchange: NYSE·Updated 07:52 PM EDT

BAX Baxter International Inc.

$24.35

$0.45

(1.88%)

Today

Closed $24.35

$0.20

(0.82%)

After Hours

EarningsOct 29

Mkt Cap$12.36B

Vol3.01M

About BAX

Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. It operates through the following segments: Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment sells connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment focuses on the sales of specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

Fundamentals

Mkt Cap

$12.36B

52W High

$30.00

52W Low

$15.73

PE Ratio

-12.63

Avg. Volume

6.76M

EPS (Annual)

-$2.05

Rev/Employee

$299,840.00

Earnings

Oct 29

Bearish Sentiment

How do you feel about BAX?

Rabbitschomb

Sep 20

$BAX I work at the old Hillrom that Baxter bought for give or take $12B. Our market cap is less than $12B now. I wonder sometimes why one of the real big boys don’t buy Baxter. It’s like buying Hillrom for $12B and get the rest for free. We have been in a hole for 4 + years. We make it to $30 for a day or 2 then right back down. Baxter has had zero influence on Hillrom. The business is being ran the exact same way as when Hillrom was in charge it. Something has got to change. Baxter at the time of purchase was $80, Hillrom $156. Don’t hate me, I am a small fry, but a Baxter investor.